logo
Mom Faces Backlash After Shocking Video of Young Son Riding on Moving Lawn Mower Goes Viral

Mom Faces Backlash After Shocking Video of Young Son Riding on Moving Lawn Mower Goes Viral

Yahoo2 days ago

Haley Orrock is a content creator known for sharing her family and lifestyle online
In May 2025, the mother-of-two posted a video of her son riding a lawn mower as her husband was mowing the backyard
Her TikTok went viral after gaining criticism onlineHaley Orrock is a stay-at-home mom and content creator known for her budget-friendly DIY projects, through which she gradually transforms her small home on her own.
With over 350,000 followers across her social media platforms, the young mother-of-two often posts content that resonates with everyday parents navigating real-life moments.
However, on May 29, 2025, Orrock shared what she believed was an innocent video of her son, Theo, and husband spending time together in the backyard – but it quickly went viral for all the wrong reasons.
Viewers were alarmed to see her young child sitting on a moving lawn mower while her husband used it to cut the grass.
'This went viral because I didn't know about kids and lawn mowers…' Orrock wrote in an updated post.
Embarrassed by the original TikTok, she ended up taking it down after noticing 'too many people weren't reading the caption."
"I realized I might be spreading a bad idea instead of awareness," she added.
Instead, she reposted the video with the hope 'of saving a few tiny fingers and toes – especially for the parents who grew up feral like me.'
Orrock urged other parents not to repeat her mistake and emphasized the importance of safety and caution, but also explained that she had grown up riding on mowers and didn't know any better.
'Looking back, it seems so obviously dangerous,' she captioned the new video. 'I'm just grateful I learned the risk before my baby got hurt.'
Nevertheless, there was a slew of conflicting comments under her new post, with most users questioning how Orrock didn't realize it was such a big deal.
'You… didn't know your toddler shouldn't perch atop of a large motorized spinning blade?' one person commented.
"What's terrifying to me is both mom AND dad didn't realize this was a bad idea?!' another wrote.
Yet, a few followers appreciated Orrock's honesty and her attempt to keep the video on her profile.
'Thank you for spreading awareness at just how unsafe this is,' one user commented. 'My husband is a paramedic & has run on too many kids hurt by lawnmowers.'
Another thanked her 'for learning and vowing to do better.'
Despite being a mother of a toddler and a newborn baby, Orrock still labels herself a 'first-time mom" who is still learning from her children every day.
'Every stage with Theo is a first for me and honestly - I don't know what I am doing most of the time,' she wrote on an Instagram story.
Orrock did not immediately respond to PEOPLE's request for comment.
Read the original article on People

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GLP-1 Less Frequent Dosing May Maintain Weight Loss
GLP-1 Less Frequent Dosing May Maintain Weight Loss

Medscape

timean hour ago

  • Medscape

GLP-1 Less Frequent Dosing May Maintain Weight Loss

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) administered at off-label reduced dosing maintained weight-loss benefits, with patients retaining the effects even with 2-4 weeks between doses. METHODOLOGY: GLP-1 RAs are transforming obesity treatment, but high costs and shortages limit patient access. Clinicians have suggested a less frequent dosing to maintain weight loss, but evidence supporting its effectiveness is lacking. Researchers used a combination of real-world case reports and mathematical modeling to examine the efficacy of a less frequent dosing of GLP-1 RAs for weight maintenance. They analyzed the data of two patients who used GLP-1 RAs at less frequent dosing schedules than recommended; patient 1 with obesity and prediabetes self-administered 7.5 mg tirzepatide every 10-14 days, whereas patient 2 with uncontrolled type 2 diabetes managed intermittent dosing of 15 mg tirzepatide due to supply shortages. A mathematical pharmacokinetic-pharmacodynamic model was used to simulate long-term changes in body weight of virtual patients administered semaglutide and tirzepatide at various dosing intervals. Simulations modeled semaglutide (2.4 mg) or tirzepatide (5 mg, 10 mg, or 15 mg) as a once-weekly dosing for 120 weeks, after which the 7-day dosing interval was increased to 10, 14, or 28 days or retained. TAKEAWAY: Patient 1 achieved an additional 13.7% body weight loss over 7 months and maintained it thereafter. Patient 2 lost 30% of her body weight and safely stopped insulin; even with intermittent dosing of tirzepatide, she retained a 22.8% body weight loss from baseline. Mathematical modeling predicted that switching from one dose per week to one dose every 2 weeks maintained 72% and 78% of the body weight loss achieved with 2.4 mg semaglutide and 15 mg tirzepatide, respectively. Even monthly dosing may have preserved half of the body weight loss achieved with weekly dosing, demonstrating that the reduction in efficacy was not proportional to the reduction in dosing frequency. IN PRACTICE: 'Future studies are needed to identify patient factors that predict a more favorable response to less frequent dosing of incretin mimetics and to examine the long-term clinical outcomes achieved through this approach compared with other off-ramping options (eg, switching to alternative AOMs [anti-obesity medications]),' the authors wrote. SOURCE: This study was led by Calvin C. Wu, Tono Health, Brooklyn, New York. It was published online in Obesity . LIMITATIONS: No limitations were provided for this study. DISCLOSURES: Two authors reported receiving funding from the National Science Foundation. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication. Credit Lead image: KKfotostock/Dreamstime Medscape Medical News © 2025 WebMD, LLC Cite this: Edited by Javed Choudhury. GLP-1 Less Frequent Dosing May Maintain Weight Loss - Medscape - June 03, 2025.

Belmont Stakes odds, post positions, favorites and analysis
Belmont Stakes odds, post positions, favorites and analysis

Washington Post

timean hour ago

  • Washington Post

Belmont Stakes odds, post positions, favorites and analysis

The 157th Belmont Stakes is Saturday night at Saratoga Race Course, the second consecutive year the race will be staged in Upstate New York because of renovations at Belmont Park, the usual host. This year's race covers 1¼ miles, shorter than Belmont's traditional 1½, and offers a $2 million purse. The field has a compelling mix of contenders, including Kentucky Derby winner Sovereignty, who returns after skipping the Preakness Stakes, and Preakness victor Journalism, each aiming to secure two legs of the Triple Crown. Other notable entrants are Hill Road, fresh off a win in the Peter Pan Stakes, and international competitor Heart of Honor, who seeks to make his mark on U.S. soil after mostly racing in Dubai.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store